Article Details

GSK shares fall 9% in wake of Zantac court ruling - Pharmaceutical Technology

Retrieved on: 2024-06-04 17:05:43

Tags for this article:

Click the tags to see associated articles and topics

GSK shares fall 9% in wake of Zantac court ruling - Pharmaceutical Technology. View article details on hiswai:

Summary

The article details litigation surrounding Zantac, leading to significant market reactions for involved pharmaceutical companies. Business intelligence in risk assessment and impact analysis is crucial for understanding the financial and legal repercussions in this scenario.

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up